You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rebif®

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Darmstadt (Rebif®)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • Rebif®
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center
Jan 16, 2018

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Rebif®, Copaxone®)

Completed
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Birmingham, Alabama
  • +79 more
Sep 15, 2017

Multiple Sclerosis, Relapsing-Remitting Trial in Germany, Sweden (Rebif®)

Completed
Has Results
  • Multiple Sclerosis
  • Relapsing-Remitting
  • Rebif®
  • Darmstadt, Germany
  • +13 more
Jul 21, 2017

Multiple Sclerosis Trial in Boston (Rebif®)

Terminated
Has Results
  • Multiple Sclerosis
  • Rebif®
  • Boston, Massachusetts
    Call EMD Serono Medical Information for information on recruitin
Nov 28, 2016

Relapsing-remitting Multiple Sclerosis Trial in Bonn (Rebif®, Avonex)

Unknown status
  • Relapsing-remitting Multiple Sclerosis
  • Bonn, Germany
  • +1 more
Jun 2, 2016

Rebif® Use in Pediatric Multiple Sclerosis Subjects

Completed
Has Results
  • Multiple Sclerosis
  • Rebif®
  • Birmingham, Alabama
  • +17 more
Apr 27, 2015

Clinically Isolated Syndrome Trial in Windsor, Barrie, Hamilton, Mississauga (Rebif®, No Treatment)

Completed
Has Results
  • Clinically Isolated Syndrome
  • Rebif®
  • No Treatment
  • Windsor, Barrie, Hamilton, Mississauga, Ontario, Canada
    Canadian Medical Information Office
Dec 2, 2013

Multiple Sclerosis, Relapsing-Remitting Trial (Rebif®, Avonex®)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • (no location specified)
Aug 2, 2013